MAA
AGN.PRA

Managed Account Advisors’s Allergan plc AGN.PRA Stock Holding History

Managed Account Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$4.87M Buy
+4,659
New +$4.88M ﹤0.01% 1437

Other funds holding AGN.PRA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Managed Account Advisors's AGN.PRA Position: Q2 2015 in Review

Managed Account Advisors opened a new position in Allergan plc (AGN.PRA) in Q2 2015: 4,659 shares worth $4.87M. The stake represents ﹤0.01% of the portfolio and ranks #1437 among its holdings.

84 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2015.

  • Managed Account Advisors held 4,659 shares of Allergan plc worth $4.87M as of Q2 2015.
  • Allergan plc was a new Managed Account Advisors position in Q2 2015.
  • Allergan plc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1437 holding.
  • 84 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.